Years of Preclinical Work on IBAL Formulations
IBAL Preclinical
We are pioneering the discovery and development of IBAL novel
patient-directed therapies targeting key signaling pathways that drive
the formation and spread of disease.
Ion Gel ZCM-25® Anti-MRSA Disinfectant Activity By a Bacterial Challenge MRSA
Public Relations
Ion Gel ZCM-25® Antifungal Disinfectant Activity by Fungicide Challenge – Aspergillus Brasiliensis
Public Relations
Ion Gel ZCM-25® cGMP Manufactured - Antivirus Test on SARS-CoV-2
Public Relations
Ion Gel ZCM-25® cGMP Manufactured - Antimicrobial Test on 3 Bacteria
Public Relations
Dermal Irritability Single High Dose Study of Ion Gel ZCM-25® on New Zealand Male Rabbits
Public Relations
ION-ZCM1 Oxygen Radical Absorbance Capacity Orac Activity Assay
Public Relations
ION-ZCM1 – Cell-Based In Vitro Toxicity Study
Public Relations
ION-ZC1 In Vitro Antimicrobial Study On Biofilm
Public Relations
ION-ZCM1 Redox Potential Assay
Public Relations
Preliminary Evaluation Of ION-ZC1 As A Potential Anticancer Agent In Vitro
Public Relations
Ion Gel ZCM-25® Skin Irritability Test -Rabbit Single Dose
Public Relations
ION-ZC1 Topical Cream Anti-Tumor Efficacy Study - Syngeneic Mouse Melanoma - 30 Mice
Public Relations
ION-ZC1 In Vitro Antimicrobial Study On MRSA
Public Relations
ION-ZC1 In Vitro Antimicrobial Study On 12 Hospital Acquired Gram-Negative - Gram-Positive Bacteria - Fungus
Public Relations
ION-ZC1 Anti-Tumor Efficacy Study By Intravenous Injection - B16 Mouse Melanoma - 30 Mice
News Team
ION-ZC1 – Acute Intravenous Toxicity in Mice
Public Relations
ION-ZC1 – 6 Pack Safety Study – Biosimilar Product Safety Study at 100% Concentration
Public Relations
